P. et al.: The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome. Cancer, 119: 3007, 2013Vickers AJ, Sjoberg DD, Ankerst DP, Tangen CM, Goodman PJ, Thompson IM Jr. The prostate cancer prevention trial risk calculator ...
A calculator based on prostate imaging reporting and data system version 2 (PI-RADS V2) is a promising prostate cancer predictorThis research is to develop a new tool to improve the performance of predicting prostate cancer (PCa) and reducing unnecessary biopsies. The clinical data of patients ...
The first version of the Prostate Cancer Risk Calculator, developed in 2006 to help men and their doctors assess their risk for prostate cancer, has been completely revamped. Version 2.0 uses current risk factors and gives a more nuanced result to help a man and his physician understand the ...
We also evaluated the Prostate Cancer Prevention Trial Risk Calculator 2.0 (PCPTRC), which yielded an AUC of 0.62 (95% CI, 0.57-0.67). In addition to the population with an initial biopsy and a PSA level of 2 to 10 ng/mL, we also evaluated performance of the assay in men with a ...
The Prostate Cancer Prevention Trial (PCPT) Prostate Cancer Risk Calculator provides a single probability of prostate cancer and of high-grade disease (Gleason grade \(\geq\) 7) based on a man's serum prostate-specific antigen (PSA) level, digital rectal examination (DRE) result, family histor...
In exploratory analysis, we evaluated the Prostate Cancer Prevention Trial (PCPT) calculator24 for high-grade disease in this validation cohort, then used logistic regression to add PCA3 and T2:ERG and evaluated differences in consequent areas under the curve (AUCs) by the Delong test. The PCPT...
Prostate cancer: ERSPC calculator recalibrated for Chinadoi:10.1038/nrurol.2016.259FennerAnnetteNature Reviews UrologyFenner A. Prostate cancer: ERSPC calculator re- calibrated for China. Nat Rev Urol 2017; 14: 66.
In conclusion, the ERSPC risk calculator outperformed both the PCPT model and the PSA threshold of 4 ng ml(-1) in predicting prostate cancer and high-grade disease in Chinese patients. However, the prediction tools derived from Western men significantly overestimated the probability of prostate ...
Text size:AAA RU PL LT EE EN NL In partnership with the European Randomized Study of Screening for Prostate Cancer News in Brief No announcement available No announcement available Calculate your prostate cancer risk A practical, private and simple way of assessing your personal risk ...
Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer Objective To modify the Prostate Cancer Prevention Trial risk calculator (PCPTRC) to predict low- vs high-grade (Gleason grade ≥7) prostate cancer and ... Donna,P.,Ankerst,... - ...